General Information of the Compound
| Compound ID |
CP0389098
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-1-acetyl-N-[(2R)-1-[[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-[4-(trifluoromethyl)phenyl]propan-2-yl]pyrrolidine-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H41F3N6O5
|
||||||||||||||||||
| Molecular Weight |
670.733
|
||||||||||||||||||
| Canonical SMILES |
CCCC[C@H](NC(=O)[C@@H](Cc1ccc(cc1)C(F)(F)F)NC(=O)[C@@H]1CCCN1C(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H41F3N6O5/c1-3-4-9-26(31(46)41-27(30(38)45)18-22-19-39-25-10-6-5-8-24(22)25)40-32(47)28(17-21-12-14-23(15-13-21)34(35,36)37)42-33(48)29-11-7-16-43(29)20(2)44/h5-6,8,10,12-15,19,26-29,39H,3-4,7,9,11,16-18H2,1-2H3,(H2,38,45)(H,40,47)(H,41,46)(H,42,48)/t26-,27-,28+,29-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DOMNZRZQNCMHNF-FKWFRFQNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01325, Melanocortin receptor 3
Protein ID: PT00914, Melanocortin receptor 4